The most common adverse reactions observed in ≥ 2% of patients in the clinical studies for Anascorp® were: vomiting, pyrexia, rash, nausea, and pruritus. Severe hypersensitivity reactions, including anaphylaxis, may occur with Anascorp®. Read more important safety information about Anascorp®. //GO